The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kobie, J. J.
Right arrow Articles by Mosmann, T. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kobie, J. J.
Right arrow Articles by Mosmann, T. R.
The Journal of Immunology, 2006, 177: 6780-6786.
Copyright © 2006 by The American Association of Immunologists, Inc.

T Regulatory and Primed Uncommitted CD4 T Cells Express CD73, Which Suppresses Effector CD4 T Cells by Converting 5'-Adenosine Monophosphate to Adenosine1

James J. Kobie, Pranav R. Shah, Li Yang, Jonathan A. Rebhahn, Deborah J. Fowell and Tim R. Mosmann2

David H. Smith Center for Vaccine Biology and Immunology and Department of Microbiology and Immunology, University of Rochester Medical Center, Rochester, NY 14642

CD73 (5'-ectonucleotidase) is expressed by two distinct mouse CD4 T cell populations: CD25+ (FoxP3+) T regulatory (Treg) cells that suppress T cell proliferation but do not secrete IL-2, and CD25 uncommitted primed precursor Th (Thpp) cells that secrete IL-2 but do not suppress in standard Treg suppressor assays. CD73 on both Treg and Thpp cells converted extracellular 5'-AMP to adenosine. Adenosine suppressed proliferation and cytokine secretion of Th1 and Th2 effector cells, even when target cells were activated by anti-CD3 and anti-CD28. This represents an additional suppressive mechanism of Treg cells and a previously unrecognized suppressive activity of Thpp cells. Infiltration of either Treg or Thpp cells at inflammatory sites could potentially convert 5'-AMP generated by neutrophils or dying cells into the anti-inflammatory mediator adenosine, thus dampening excessive immune reactions.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by National Institutes of Health Grants RO1 AI48604 and T32 CA09363-22 (to J.J.K.).

2 Address correspondence and reprint requests to Dr. Tim R. Mosmann, David H. Smith Center for Vaccine Biology and Immunology, University of Rochester Medical Center, 601 Elmwood Avenue, Box 609, Rochester, NY 14642. E-mail address: Tim_Mosmann{at}urmc.rochester.edu

3 Abbreviations used in this paper: Thpp, primed precursor Th cells; APCP, {alpha},β-methylene ADP.




This article has been cited by other articles:


Home page
J. Immunol.Home page
S. P. Hilchey, J. J. Kobie, M. R. Cochran, S. Secor-Socha, J.-C. E. Wang, O. Hyrien, W. R. Burack, T. R. Mosmann, S. A. Quataert, and S. H. Bernstein
Human Follicular Lymphoma CD39+-Infiltrating T Cells Contribute to Adenosine-Mediated T Cell Hyporesponsiveness
J. Immunol., November 15, 2009; 183(10): 6157 - 6166.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
A. Ohta, A. Ohta, M. Madasu, R. Kini, M. Subramanian, N. Goel, and M. Sitkovsky
A2A Adenosine Receptor May Allow Expansion of T Cells Lacking Effector Functions in Extracellular Adenosine-Rich Microenvironments
J. Immunol., November 1, 2009; 183(9): 5487 - 5493.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Mandapathil, M. J. Szczepanski, M. Szajnik, J. Ren, D. E. Lenzner, E. K. Jackson, E. Gorelik, S. Lang, J. T. Johnson, and T. L. Whiteside
Increased Ectonucleotidase Expression and Activity in Regulatory T Cells of Patients with Head and Neck Cancer
Clin. Cancer Res., October 15, 2009; 15(20): 6348 - 6357.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
G. R. Kinsey, R. Sharma, L. Huang, L. Li, A. L. Vergis, H. Ye, S.-T. Ju, and M. D. Okusa
Regulatory T Cells Suppress Innate Immunity in Kidney Ischemia-Reperfusion Injury
J. Am. Soc. Nephrol., August 1, 2009; 20(8): 1744 - 1753.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
L.-F. Lu and A. Rudensky
Molecular orchestration of differentiation and function of regulatory T cells
Genes & Dev., June 1, 2009; 23(11): 1270 - 1282.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
J. M. Wilson, W. G. Ross, O. N. Agbai, R. Frazier, R. A. Figler, J. Rieger, J. Linden, and P. B. Ernst
The A2B Adenosine Receptor Impairs the Maturation and Immunogenicity of Dendritic Cells
J. Immunol., April 15, 2009; 182(8): 4616 - 4623.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
T. Bopp, N. Dehzad, S. Reuter, M. Klein, N. Ullrich, M. Stassen, H. Schild, R. Buhl, E. Schmitt, and C. Taube
Inhibition of cAMP Degradation Improves Regulatory T Cell-Mediated Suppression
J. Immunol., April 1, 2009; 182(7): 4017 - 4024.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
F. Jeffe, K. A. Stegmann, F. Broelsch, M. P. Manns, M. Cornberg, and H. Wedemeyer
Adenosine and IFN-{alpha} synergistically increase IFN-{gamma} production of human NK cells
J. Leukoc. Biol., March 1, 2009; 85(3): 452 - 461.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B. Csoka, L. Himer, Z. Selmeczy, E. S. Vizi, P. Pacher, C. Ledent, E. A. Deitch, Z. Spolarics, Z. H. Nemeth, and G. Hasko
Adenosine A2A receptor activation inhibits T helper 1 and T helper 2 cell development and effector function
FASEB J, October 1, 2008; 22(10): 3491 - 3499.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. V. Sitkovsky, J. Kjaergaard, D. Lukashev, and A. Ohta
Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia
Clin. Cancer Res., October 1, 2008; 14(19): 5947 - 5952.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
A. Liston, L.-F. Lu, D. O'Carroll, A. Tarakhovsky, and A. Y. Rudensky
Dicer-dependent microRNA pathway safeguards regulatory T cell function
J. Exp. Med., September 1, 2008; 205(9): 1993 - 2004.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. H. Mills, L. F. Thompson, C. Mueller, A. T. Waickman, S. Jalkanen, J. Niemela, L. Airas, and M. S. Bynoe
CD73 is required for efficient entry of lymphocytes into the central nervous system during experimental autoimmune encephalomyelitis
PNAS, July 8, 2008; 105(27): 9325 - 9330.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. J. Winstead, J. M. Fraser, and A. Khoruts
Regulatory CD4+CD25+Foxp3+ T Cells Selectively Inhibit the Spontaneous Form of Lymphopenia-Induced Proliferation of Naive T Cells
J. Immunol., June 1, 2008; 180(11): 7305 - 7317.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Takedachi, D. Qu, Y. Ebisuno, H. Oohara, M. L. Joachims, S. T. McGee, E. Maeda, R. P. McEver, T. Tanaka, M. Miyasaka, et al.
CD73-Generated Adenosine Restricts Lymphocyte Migration into Draining Lymph Nodes
J. Immunol., May 1, 2008; 180(9): 6288 - 6296.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Jalkanen and M. Salmi
VAP-1 and CD73, Endothelial Cell Surface Enzymes in Leukocyte Extravasation
Arterioscler Thromb Vasc Biol, January 1, 2008; 28(1): 18 - 26.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
G. Borsellino, M. Kleinewietfeld, D. Di Mitri, A. Sternjak, A. Diamantini, R. Giometto, S. Hopner, D. Centonze, G. Bernardi, M. L. Dell'Acqua, et al.
Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression
Blood, August 15, 2007; 110(4): 1225 - 1232.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
S. Deaglio, K. M. Dwyer, W. Gao, D. Friedman, A. Usheva, A. Erat, J.-F. Chen, K. Enjyoji, J. Linden, M. Oukka, et al.
Adenosine generation catalyzed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression
J. Exp. Med., June 11, 2007; 204(6): 1257 - 1265.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2006 by The American Association of Immunologists, Inc. All rights reserved.